These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618 [TBL] [Abstract][Full Text] [Related]
3. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441 [TBL] [Abstract][Full Text] [Related]
4. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505 [TBL] [Abstract][Full Text] [Related]
5. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits. Björn I; Bäckström T; Lalos A; Sundström-Poromaa I Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659 [TBL] [Abstract][Full Text] [Related]
6. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. Baker ER; Best RG; Manfredi RL; Demers LM; Wolf GC J Assist Reprod Genet; 1995 Mar; 12(3):205-9. PubMed ID: 8520187 [TBL] [Abstract][Full Text] [Related]
8. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone. Andréen L; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström T Psychopharmacology (Berl); 2006 Aug; 187(2):209-21. PubMed ID: 16724185 [TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Maddocks S; Hahn P; Moller F; Reid RL Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587 [TBL] [Abstract][Full Text] [Related]
10. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
11. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949 [TBL] [Abstract][Full Text] [Related]
12. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Hammarbäck S; Bäckström T; Holst J; von Schoultz B; Lyrenäs S Acta Obstet Gynecol Scand; 1985; 64(5):393-7. PubMed ID: 4061059 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women. Ross D; Cooper AJ; Pryse-Davies J; Bergeron C; Collins WP; Whitehead MI Am J Obstet Gynecol; 1997 Oct; 177(4):937-41. PubMed ID: 9369848 [TBL] [Abstract][Full Text] [Related]
15. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358 [TBL] [Abstract][Full Text] [Related]
16. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. Freeman E; Rickels K; Sondheimer SJ; Polansky M JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047 [TBL] [Abstract][Full Text] [Related]
17. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. Hammarbäck S; Damber JE; Bäckström T J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857 [TBL] [Abstract][Full Text] [Related]
18. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462 [TBL] [Abstract][Full Text] [Related]
19. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. Graham CA; Sherwin BB J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678 [TBL] [Abstract][Full Text] [Related]